Quantbot Technologies LP Has $12.62 Million Stake in Cardinal Health, Inc. $CAH

Key Points

• Quantbot Technologies LP increased its stake in Cardinal Health, Inc. by 19.8%, acquiring an additional 15,168 shares during the first quarter, bringing its total holdings to 91,613 shares valued at approximately $12.62 million.
• Cardinal Health announced a quarterly dividend of $0.5107 per share, with a record date of October 1, resulting in an annualized dividend yield of 1.4%.
• Analysts maintain a consensus rating of "Moderate Buy" for Cardinal Health, with an average target price of $163.20, following multiple positive upgrades from various financial institutions.

Quantbot Technologies LP grew its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 19.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 91,613 shares of the company's stock after buying an additional 15,168 shares during the quarter. Quantbot Technologies LP's holdings in Cardinal Health were worth $12,622,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Wellington Management Group LLP increased its stake in Cardinal Health by 1,666.7% in the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company's stock valued at $328,470,000 after purchasing an additional 2,249,241 shares during the last quarter. Castlekeep Investment Advisors LLC acquired a new position in Cardinal Health in the fourth quarter valued at $141,963,000. JPMorgan Chase & Co. increased its stake in Cardinal Health by 40.0% in the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company's stock valued at $575,327,000 after purchasing an additional 1,193,983 shares during the last quarter. GAMMA Investing LLC grew its position in Cardinal Health by 17,589.1% during the first quarter. GAMMA Investing LLC now owns 964,941 shares of the company's stock valued at $132,940,000 after acquiring an additional 959,486 shares during the period. Finally, Junto Capital Management LP purchased a new stake in Cardinal Health during the fourth quarter valued at about $92,811,000. Hedge funds and other institutional investors own 87.17% of the company's stock.

Cardinal Health Stock Down 2.3%

Shares of CAH traded down $3.5270 during mid-day trading on Friday, reaching $148.0430. The company's stock had a trading volume of 2,685,985 shares, compared to its average volume of 2,527,078. The business has a fifty day moving average of $159.02 and a 200 day moving average of $145.33. The company has a market cap of $35.35 billion, a price-to-earnings ratio of 22.95, a price-to-earnings-growth ratio of 1.28 and a beta of 0.67. Cardinal Health, Inc. has a 1 year low of $106.54 and a 1 year high of $168.44.

Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The company had revenue of $60.16 billion during the quarter, compared to analyst estimates of $60.91 billion. During the same quarter in the prior year, the company earned $1.84 earnings per share. The company's revenue for the quarter was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be issued a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a dividend yield of 1.4%. The ex-dividend date is Wednesday, October 1st. Cardinal Health's dividend payout ratio (DPR) is currently 31.63%.

Analyst Ratings Changes

CAH has been the subject of a number of research reports. Citigroup reissued a "neutral" rating and set a $170.00 price target (up previously from $157.00) on shares of Cardinal Health in a research report on Friday, June 13th. Wells Fargo & Company reiterated an "overweight" rating and issued a $185.00 price target (up previously from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. Jefferies Financial Group set a $150.00 price objective on Cardinal Health in a research note on Tuesday, August 12th. Bank of America upped their price objective on Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a research note on Tuesday, June 10th. Finally, UBS Group reaffirmed a "buy" rating on shares of Cardinal Health in a report on Tuesday, August 12th. Twelve research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $163.20.

Insider Buying and Selling at Cardinal Health

In related news, CEO Stephen M. Mason sold 41,575 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the sale, the chief executive officer directly owned 26,085 shares in the company, valued at approximately $3,881,969.70. This trade represents a 61.45% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Ola M. Snow sold 28,151 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the transaction, the insider directly owned 15,431 shares in the company, valued at $2,298,293.14. The trade was a 64.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 271,676 shares of company stock valued at $40,489,525 in the last quarter. Corporate insiders own 0.09% of the company's stock.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.